Islamic Republic of Afghanistan Ministry of Public Health Nangarhar Public Health Directorate Atiqurahman Thalassemia Center.
The memorable center was launched on 26th May 2017 with the aim treat Thalassemia patients and have the ability to treat 20 patients at a time. The personnel salaries and related possibilities are given by the national trader Atiqurahman Hadawal.
To Solve patients’ problem of blood donation and smooth the ground for future collaboration with other advanced hospitals to provide facilities for treatment of these patients.
Transfusions of red blood cells are the main treatment for people who have moderate or severe thalassemia’s. This treatment gives you healthy red blood cells with normal hemoglobin.
During a blood transfusion, a needle is used to insert an intravenous (IV) line into one of your blood vessels. Through this line, you receive healthy blood. The procedure usually takes 1 to 4 hours.
Splenectomy has in the past played a major role in the treatment of thalassemia, but increased awareness of its adverse effects have significantly decreased its use. When the surgical procedure is necessary measures must be taken in order to protect the patient from the risk of infection and thrombosis.
The hemoglobin in red blood cells is an iron-rich protein. Thus, regular blood transfusions can lead to a buildup of iron in the blood. This condition is called iron overload. It damages the liver, heart, and other parts of the body.
To prevent this damage, doctor’s use iron chelation therapy to remove excess iron from the body. Two medicines are used for iron chelation therapy.
ATC maintains a real-time database of patients’ treatment and statistics. The figures below are updated in a scheduled fetch data operation: